Parallel Advisors, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 121 shares of EYPT stock, worth $690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121Holding current value
$690% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
157Shares Held
72.7MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$47.5 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$38.7 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$32.8 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$23.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$21.7 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $195M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...